Fagron Sustainability Profile
Fagron, a leading global player in the pharmaceutical industry, is headquartered in the Netherlands (NL) and operates extensively across Europe, North America, and Latin America. Founded in 1990, the company has established itself as a pioneer in customised medicines, focusing on compounding and innovative pharmaceutical solutions tailored to individual patient needs. Fagron's core offerings include a diverse range of pharmaceutical products and services, such as sterile and non-sterile compounding, as well as advanced drug delivery systems. What sets Fagron apart is its commitment to quality and innovation, ensuring that healthcare professionals have access to tailored therapies that enhance patient outcomes. With a strong market position and a reputation for excellence, Fagron continues to achieve significant milestones in the pharmaceutical sector, reinforcing its status as a trusted partner in personalised medicine.
DitchCarbon Score
How does Fagron's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Fagron's score of 67 is higher than 82% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Fagron's reported carbon emissions
In 2024, Fagron, headquartered in the Netherlands, reported total greenhouse gas emissions of approximately 293,227,000 kg CO2e. This figure includes 3,871,000 kg CO2e from Scope 1 emissions, 6,554,000 kg CO2e from Scope 2 (market-based), and a significant 282,802,000 kg CO2e from Scope 3 emissions. The company has set ambitious targets to reduce its absolute Scope 1 and 2 emissions by 42% by 2030, using 2021 as the baseline year. Additionally, Fagron aims to cut its Scope 3 emissions by 25% across selected categories within the same timeframe. In 2023, Fagron's total emissions were approximately 273,399,000 kg CO2e, with Scope 1 emissions at 4,274,000 kg CO2e, Scope 2 emissions (market-based) at 8,639,000 kg CO2e, and Scope 3 emissions at 260,486,000 kg CO2e. This indicates a slight increase in total emissions compared to 2024, highlighting the ongoing challenges in emission reductions. Fagron's commitment to sustainability is further underscored by its goal for 60% of its suppliers, by emissions, to have science-based targets by 2027. The company's targets are aligned with the Science Based Targets initiative (SBTi), ensuring that their reduction strategies are consistent with the global aim to limit warming to 1.5°C. Overall, Fagron is actively working towards significant reductions in its carbon footprint, demonstrating a commitment to environmental responsibility within the healthcare equipment and supplies sector.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Scope 1 | 2,818,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 8,200,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 3 | 2,477,000 | 000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
How Carbon Intensive is Fagron's Industry?
How Carbon Intensive is Fagron's Location?
Fagron's Scope 3 Categories Breakdown
Fagron's Scope 3 emissions, which increased by 9% last year and increased significantly since 2019, demonstrating supply chain emissions tracking. Nearly all of their carbon footprint comes from suppliers and value chain emissions, representing nearly all emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 59% of Scope 3 emissions.
Top Scope 3 Categories
Fagron's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Fagron has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Diplomat Pharmacy, Inc.
Frequently Asked Questions
Common questions about Fagron's sustainability data and climate commitments